Medidata is engaging with regulators to advise on the future of clinical trials, but CEO Tarek Sherif cautions against getting overhyped about new innovations.
Journey Medical has claimed FDA approval for its Emrosi therapy for rosacea, which it thinks could become a "standard of care" drug for the common skin disorder.
Investigator sites are essential for successful execution of clinical trials – ensuring studies are conducted ethically, safely, and in compliance with regulatory standards.